A jury in Pennsylvania has awarded $27.8 million to an Indiana couple over a severe bleed caused by the bloodthinner Xarelto. Lynn Hartmann and her husband alleged that pharmaceutical giants Bayer AG and Johnson & Johnson failed to warn them about the risk of severe bleeding events associated with the use of Xarelto.
Bayer Pharmaceuticals, a division of Johnson & Johnson, is facing about 6,400 federal lawsuits filed by patients who suffered complications from the bloodthinner Xarelto (rivaroxoaban). The first four of these lawsuits is scheduled to go to trial in early 2017 in U.S. District Court for the Eastern District of Louisiana.
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals unit are facing more than 5,000 lawsuits filed by patients who suffered severe bleeding or other complications linked to the bloodthinner drug Xarelto. The 5,000 pending Xarelto lawsuits including thousands of complaints that were consolidated in a multidistrict litigation (MDL) in Louisiana and several hundred more lawsuits consolidated…
The Food and Drug Administration has launched an investigation into whether a faulty blood monitor may have compromised testing results that led to the agency’s approval of the bloodthinner Xarelto. Xarelto has been prescribed to millions of Americans since it was approved by the FDA and placed on the market in 2011.
Some of the people pursuing Xarelto bleeding lawsuits have requested that all Xaretlo cases pending in federal courts around the country be brought together in a single U.S. district court for pre-trial proceedings. The request, filed with the United States Judicial Panel of Multidistrict Litigation (JPML), proposes a multidistrict proceeding to oversee all federal Xarelto…
When having hip or knee replacement surgery, your healthcare provider may have prescribed rivaroxaban to prevent blood clots after the procedure. Invented and manufactured by Bayer, rivaroxaban it is marketed by Janssen Pharmaceutica as Xarelto. This blood-thinning medicine can also prevent blood clots and strokes in people with atrial fibrillation. Unlike other blood-thinning drugs that…